EicOsis Human Health

CompanyUnited States

EicOsis Human Health develops one asset, in phase 1 (EC5026 in chronic kidney disease). Mostly small molecule; based in the United States.

1
Asset
Furthest stage
Phase 1
6
Trials
0
Signals

Pipeline

1
  • EC5026

    Soluble epoxide hydrolase (sEH) inhibitor

    Phase 1, Small molecule, chronic kidney disease, degenerative disc disease

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials6
  • Signals1
  • Similar companies6

Intelligence